MoneyWorks4Me

Venus Remedies - Quaterly Results

04 Feb 2025 Evaluate
The sales surged to Rs. 1725.40 millions, up 31.48% for the December 2024 quarter as against Rs. 1312.30 millions during the corresponding quarter previous year.The Net Profit of the company reported a remarkable increase of 194.02% to Rs. 240.80  millions  from Rs. 81.90 millions in previous same quarter.OP of the company witnessed a marginal growth to 246.50 millions from 154.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1725.40 1312.30 31.48 4454.20 4000.50 11.34 5752.10 5376.60 6.98
Other Income 17.40 24.20 -28.10 140.10 74.10 89.07 113.20 101.70 11.31
PBIDT 246.50 154.20 59.86 614.70 470.10 30.76 722.00 717.00 0.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 345.60 154.20 124.12 713.80 470.10 51.84 722.00 717.00 0.70
Depreciation 52.00 63.00 -17.46 171.30 198.30 -13.62 255.50 313.70 -18.55
PBT 293.60 91.20 221.93 542.50 271.80 99.60 466.50 403.30 15.67
TAX 52.80 9.30 467.74 164.60 92.00 78.91 161.50 113.70 42.04
Deferred Tax -21.00 11.60 -281.03 28.20 23.60 19.49 39.30 113.70 -65.44
PAT 240.80 81.90 194.02 377.90 179.80 110.18 305.00 289.60 5.32
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 14.29 11.75 21.58 13.80 11.75 17.44 12.55 13.34 -5.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..